Form 4 for AVNT AVIENT CORP
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0001127602-21-029442 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-17 | 2021-11-15 | AVNT | Kunkle Lisa K. | SVP Gnrl Counsel, Sec | D - Sale to Iss | $59.58 | -26.1K | 77.3K | -25% | -$1.55M |
| D | 2021-11-17 | 2021-11-16 | AVNT | Kunkle Lisa K. | SVP Gnrl Counsel, Sec | S - Sale+OE | $60.22 | -11.4K | 69.6K | -14% | -$689.3K |
| DM | 2021-11-17 | 2021-11-15 | AVNT | Kunkle Lisa K. | SVP Gnrl Counsel, Sec | M - OptEx | $29.38 | +37.5K | 88.8K | +73% | +$1.10M |
| DM | 2021-11-17 | 2021-11-15 | AVNT | Kunkle Lisa K. | SVP Gnrl Counsel, Sec | M - OptEx | $0.00 | -37.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | D | D | 7,784 | $59.58 | 81,057 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-16 | S | D | 11,447 | $60.22 | 69,610 | D | — | — | (F1) The sale price is a weighted average for the sale transactions. The sales prices range from a low of $59.44 per share to a high of $60.84. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, Avient Corporation or a security holder of Avient Corporation. |
| 3 | Common | Common Stock | 2021-11-15 | M | A | 10,400 | $23.08 | 80,010 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-15 | D | D | 5,984 | $59.58 | 74,026 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-15 | M | A | 7,100 | $35.07 | 81,126 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-15 | D | D | 5,476 | $59.58 | 75,650 | D | — | — | |
| 7 | Common | Common Stock | 2021-11-15 | M | A | 8,500 | $38.27 | 84,150 | D | — | — | |
| 8 | Common | Common Stock | 2021-11-15 | D | D | 6,809 | $59.58 | 77,341 | D | — | — | |
| 9 | Common | Common Stock | 2021-11-15 | M | A | 11,500 | $24.98 | 88,841 | D | — | — | |
| 10 | Derivative | Stock Appreciation Rights | 2021-11-15 | M | D | 7,100 | $0.00 | 0 | D | $35.07 · — to 2024-02-11 | 7,100 Common Stock | (F4) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years. |
| 11 | Derivative | Stock Appreciation Rights | 2021-11-15 | M | D | 10,400 | $0.00 | 0 | D | $23.08 · — to 2023-02-15 | 10,400 Common Stock | (F3) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $23.08 per share and no more than one-third of the grant can vest per year during the first three years. |
| 12 | Derivative | Stock Appreciation Rights | 2021-11-15 | M | D | 11,500 | $0.00 | 0 | D | $24.98 · — to 2026-02-10 | 11,500 Common Stock | (F6) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years. |
| 13 | Derivative | Stock Appreciation Rights | 2021-11-15 | M | D | 8,500 | $0.00 | 0 | D | $38.27 · — to 2025-02-04 | 8,500 Common Stock | (F5) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years. |